(4-020) Establishing a Rifaximin Criteria for Use Protocol for Hepatic Encephalopathy

Monday, December 5, 2022

2:00 PM – 3:30 PM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Drug Information/Drug Use Evaluation

Co-Author(s): Stephanie Palma, Erika Dittmar, Heidi Clarke

Primary Author(s)

Allison M. Vargas, PharmD
PGY2 Critical Care Pharmacy Resident
Baptist Hospital of Miami, Florida